GlassScriptPhysician profile
Bill Liu
NPI 1225482953
$1,234.80
in general payments reported to CMS, 2019-2025
15 companies · $542 in 2025
The $542 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $162 · 2023: $200 · 2024: $331 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $476.44 | 2022-2025 | Stravix, Oasis Micro, Stravix Pl |
| Vertex Pharmaceuticals Incorporated | $112.04 | 2025 | |
| Davol INC. | $108.75 | 2024-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Kci USA, INC. | $99.30 | 2022-2023 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Avita Medical Americas, LLC | $93.23 | 2025 | Recell, Cohealyx, Permeaderm |
| Polynovo North America LLC | $90.23 | 2024 | Novosorb Btm |
| Hydrofera LLC | $50.19 | 2022-2025 | Leukomed Sorbact |
| Abbvie INC. | $44.23 | 2025 | |
| Medline Industries LP | $33.87 | 2023 | Medline Industries, INC. |
| Becton, Dickinson and Company | $32.87 | 2024 | Arista Ah Flexitip |
| Access Pro Medical, LLC | $21.66 | 2025 | Matriderm |
| Solventum Corporation | $20.84 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Kerecis Limited | $19.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $16.93 | 2023 | |
| Mimedx Group, INC. | $15.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.